Samil Pharmaceutical Co.,Ltd (KRX:000520)

KRX:000520 Revenue

Samil Pharmaceutical Co.,Ltd had revenue of 51.18B KRW in the quarter ending September 30, 2025, a decrease of -4.02%. This brings the company's revenue in the last twelve months to 215.04B, up 1.23% year-over-year. In the year 2024, Samil Pharmaceutical Co.,Ltd had annual revenue of 219.70B with 11.89% growth.

• Revenue (ttm): 215.04B
• Revenue Growth: +1.23%
• P/S Ratio: 1.01
• Revenue / Employee: 368.85M
• Employees: 583
• Market Cap: 218.03B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	219.70B	23.35B	11.89%
Dec 31, 2023	196.35B	16.67B	9.28%
Dec 31, 2022	179.68B	45.43B	33.84%
Dec 31, 2021	134.25B	11.25B	9.14%
Dec 31, 2020	123.00B	1.89B	1.56%